Conrad Arnfinn Bjørshol

Quick facts

Marketed products

• Bupivacaine-fentanyl elective group · Anesthesia and Pain Management
  Bupivacaine is a local anesthetic that blocks sodium channels in nerve fibers, while fentanyl is an opioid agonist that binds to mu opioid receptors to provide analgesia, together delivering regional anesthesia and analgesia for elective procedures.
• Bupivacaine-fentanyl emergency group · Anesthesia, Emergency Medicine, Pain Management
  Bupivacaine provides local anesthesia by blocking sodium channels in nerve fibers, while fentanyl provides opioid analgesia by binding to mu opioid receptors.
• Bupivacaine-fentanyl-morphine elective group · Anesthesia/Pain Management
  This is a combination of three analgesic agents—bupivacaine (local anesthetic), fentanyl (opioid), and morphine (opioid)—that work together to provide local anesthesia and systemic pain relief for elective surgical procedures.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Conrad Arnfinn Bjørshol portfolio CI brief
• Conrad Arnfinn Bjørshol pipeline updates RSS